Skip Navigation


European Heart Journal Advance Access originally published online on January 31, 2006
European Heart Journal 2006 27(8):895-896; doi:10.1093/eurheartj/ehi756
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/8/895    most recent
ehi756v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Domanski, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Domanski, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Prognosis in atrial fibrillation

Michael Domanski*

The Clinical Trials Group, National Heart, Lung, and Blood Institute, Bethesda, MD 20892, USA

* Corresponding author. Tel: +301 435 0399; fax: +301 480 3667.E-mail address: domanskm@nih.gov

This editorial refers to ‘Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades’{dagger} by Y. Miyasaka et al., on page 936

The first 10% of the full text of this article appears below.

The public health importance of a disease is related to the number of people affected and to the mortality and morbidity that it causes. This metric underscores the clinical importance of atrial fibrillation (AF). AF is the most common of the supraventricular arrhythmias. Recent data suggest that there are 2.3 million individuals with AF in the USA alone.1 Also, there is a strong association of AF with advancing age. About 1% of individuals between 60 and 69 years of age have AF but this rises to 5% for individuals older than 69 years and to 9% for individuals in their ninth decade.2,3 With the known, dramatic aging of the population, the number will climb to more than five million by mid-century.1 Aging of . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades
Yoko Miyasaka, Marion E. Barnes, Bernard J. Gersh, Stephen S. Cha, Kent R. Bailey, Walter Abhayaratna, James B. Seward, Toshiji Iwasaka, and Teresa S.M. Tsang
EHJ 2006 27: 936-941. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
J. J. Bax, B. De Bruyne, A. K. Gitt, S. Kristensen, C. Linde, D. Poldermans, F. J. Pinto, P. Ponikowski, B. D. Prendergast, E. Abagiti-Rosei, et al.
Highlights of the 2006 Scientific Sessions of the European Society of Cardiology: Barcelona, Spain, September 2-5, 2006
J. Am. Coll. Cardiol., December 19, 2006; 48(12): 2564 - 2574.
[Full Text] [PDF]

Home page
 Journal Watch CardiologyHome page
Heart Failure in AFib Patients: Still Common and Deadly
Journal Watch Cardiology, June 1, 2006; 2006(601): 4 - 4.
[Full Text]